P41001 AF NFT

DNA topoisomerase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihda4yxmejxelcx2ifddbw47pquki7gtrmbceuheipv34p2ugdw5y/metadata.json
IPFS of structure file: 
bafybeic5ntz3kz3mgwwo6m5v5nsyk4ouf3il76755yarrspsmscmn4c6sa/AF-P41001-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x84C29Ef3da704f3F8077E18d9E11eBbbA2488271
First NFT owner address (bech32): 
genesis1snpfau76wp8nlqrhuxxeuy0thw3y3qn3h4pvag
Current NFT ID #470033 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
470033
Accession (UniProt):
P41001
Name::
DNA topoisomerase 2
Experimental Method:
Predicted structure
Sequence source:
Plasmodium falciparum (isolate K1 / Thailand)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P41001 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P41001|TOP2_PLAFK DNA topoisomerase 2 OS=Plasmodium falciparum (isolate K1 / Thailand) OX=5839 GN=TOP2 PE=3 SV=1 MAKNKTIEERYQKKSQIEHILLRPDTYIGSVEMHTQLLWVWNKEKNRMVQKNITYVPGLYKIFDEIIVNAADVKAREKEKSENPMTCIKIEINKENKRISVYNDGEGIPVDIHKEMNIYVPHMIFGELLTSDNYDDAEDRITGGRNGFGAKLTNIFSKEFIVQCGDSSRKKEFKMTWSDNMSKFSEPHIKNYNGKDYVKVTFKPDLNKFGMTEMDDDIESLLFKRVYDLAGTCSVRVYLNGQRLAVKDFKSYVDLYLKDNSNDNKNNKGQNDNNNNNNNNNDENANQNNDNLDVSLSNEPADGTPTKNNNNNNNNNDEDEIVKIHEKQHRWEIVVSKSDGSQFQQVSFVNSICTTKGGSHVNYIVEQLLSSLSKKANAKNKGGMEIKSGHIRNHLWVFVNCLIVNPTFDSQTKETLTTKPVKFGSKCILSDKTINNVLKSPILSNILLWAQAKAQVELKKKMKAGSSKARERIIGIPKLEDANDAGSKYSQECTLILTEGDSAKTSCLAGLSIVGRDKYGVFPLKGKLLNVRDASFKQLMDNKEIQNIFRIMGLDITDKNKDDIKGLRYGSLMIMTDQDYDGSHIKGLLINMIHKFWPSLLKHKGFLSEFVTPIVKVQKGSQEYSFFTIAEYEQWKENTNLLGWKIKYYKGLGTSTDREFKQYFSDIKNHKIMFLWTGDRDGDSIDMAFSKKRIEDRKLWLQNFILGSYVDHKEKDLSYYDFVNKELIYYSRYDTERSIPNIMDGWKPGQRKVLYGCFKRNLRNECKVAQLVGYIAEHSAYHHHGESSLQQTIINMAQTFVGSNNINFLEPCGQFGSRKEGGKDASAARYIFTKLASSTRSIFNEYDDPILKYLNEEGQKIEPQYYIPVIPTILVNGCEGIGTGYSSFIPNYNYKDIIDNIKRYINKEPLIPMVPWYKDFKGRIESNGKTGYETIGIINKIDNDTLEITELPIKKWTQDYKEFLEELLTDEKHQLILDYIDNSSHEDICFTIKMDPAKLQKAEEEGLEKVFKLKSTLTTTNMTLFDPNLKLQRYSTELDILKEFCYQRLKAYENRKSYLISKLEKEKRIISNKTKFILAIVNNELIVNKKKKKVLVEELYRKGYDPYKDINKIKKEEIFEQELLDAADNPEDNEEIIAGITVKDYDYLLSMPIFSLTLEKVEDLLTQLKEKERELEILRNITVETMWLKDIEKVEEAIEFQRNVELSNREESNKFKVARKQGPSSMKKKKKKKKLSSDEESEGGDTSDSSEFLVNTLNIKKNTNKKTTTSSNNVNNSKKRLRKADDLNSNELDNTLSVSKTFDDNNNLTDNTPLINRLNDENNEFSSNNVDNKSTNKNSRKKKPKIADSTNDNNSELNSSIQINDNVNDDINITISPNKTINVNEFSSIKNKLLELGI